Registration Options

Activity Dates: 04/24/2020 - 04/24/2023

Target Audience

This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.

Session Summary

CPNP members share their experiences dealing with clinical problems. Pearls include an esketamine clinic, pain management and buprenorphine, and haloperidol as a non-opioid alternative in the ED.

Development of an Esketamine Administration Clinic

Megan Ehret, PharmD, MS, BCPP

The presentation will briefly cover the process for the development of an esketamine administration clinic and the role of a pharmacist in the clinic. Discussion of the policies and procedures currently being utilized at the University of Maryland Medical Center will be discussed.

Acute Pain Management and Buprenorphine: Paradigm Shift

Giulia Barlow, PharmD, BCPS

The use of buprenorphine-containing products for chronic pain or medication-assisted treatment (MAT) has greatly increased in the wake of the opioid epidemic. However, buprenorphine's unique agonist-antagonist pharmacology may cause confusion on how to treat acute anticipated or unanticipated pain. The Providers’ Clinical Support System (PCSS) for MAT attempted to bridge this gap in the literature by offering guidance on managing patients on buprenorphine-containing products during hospitalizations. The PCSS's recommendations were based largely on in-vitro and theoretical data; newer literature based on clinical practice questions previous guidelines. This clinical pearl will bring awareness to the new recommendations and provide suggestions for implementing them into your practice.

Haloperidol as a Non-opioid Alternative for Chronic Abdominal Pain/Headache in the Emergency Department

Elizabeth Davis, PharmD, BCPS

The current state of the opioid crisis led to the creation of evidence based non-opioid alternatives for acute pain management in the Emergency Department (ED). With the creation of these order sets, haloperidol was added for the treatment of chronic abdominal pain and headache. This clinical pearl will describe the mechanism by which haloperidol may be effective, summarize the data describing its effectiveness and discuss potential consequences for utilizing haloperidol for chronic abdominal pain or headache in the Emergency Department.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information

Megan J. Ehret, PharmD, MS, BCPP
Giulia Barlow, PharmD, BCPS
Elizabeth Davis, PharmD, BCPS

View biographical information

Learning Objectives

Development of an Esketamine Administration Clinic

  1. Describe the process for development of an esketamine administration clinic.
  2. Discuss the role of a pharmacist in an esketamine administration clinic.

Acute Pain Management and Buprenorphine: Paradigm Shift

  1. Describe previous and current recommendations for treating acute pain in patients on buprenorphine.
  2. Recall strategies to effectively manage acute pain in hospitalized patients maintained on buprenorphine.

Haloperidol as an Alternative to Opioids for Chronic Abdominal Pain/Headache in the Emergency Department

  1. Describe the mechanism of action by which haloperidol may be effective for the treatment of chronic abdominal pain or headache.
  2. Summarize the literature and studies for haloperidol as an opioid alternative.
  3. Discuss potential consequences for utilizing haloperidol as an alternative to opioids in the Emergency Department.

Continuing Education Credit and Disclosures

Activity Dates: 04/24/2020 - 04/24/2023
ACPE Contact Hours: 1
ACPE Number: 0284-0000-20-032-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.